Co-treatment with sodium lactate and DSS reduced the expression of IL-6, IL-18, and IL-1β in IPEC-J2 cells, indicating that the dual targeting of apoptosis and cytokine storm by lactate may synergistically slow the progression of IBD. This evidence concerns the gene IL1B and inflammatory bowel disease.